| Name | lysozyme |
|---|---|
| Synonyms | LYZ; LZM; Lysozyme; Lysozyme C; Lysozyme C precursor; Lysozymes; Lysozyme Cs; Lysozyme C precursors |
| Name | benzyl benzoate |
|---|---|
| CAS | phenylmethyl benzoate |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 17560056 | Chhabra S, Sachdeva V, Singh S: Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system. Int J Pharm. 2007 Sep 5;342(1-2):72-7. Epub 2007 May 6. Phase-sensitive in situ gel forming controlled release formulations of lysozyme were prepared using poly lactic acid (PLA) and/or poly (PGA) based polymers differing in end groups in addition to composition, and a solvent system consisting of various ratios of benzyl benzoate (BB) and benzyl (BA). |
10(0,0,1,5) | Details |
| 15129985 | Singh S, Singh J: Controlled release of a model protein lysozyme from phase sensitive smart polymer systems. Int J Pharm. 2004 Mar 1;271(1-2):189-96. Four different formulations, using D,L-poly (lactide) (D,L-PLA) and a solvent mixture of different ratios of benzyl benzoate (BB) and benzyl (BA), were prepared. |
7(0,0,0,7) | Details |
| 19803503 | Miller MA, Engstrom JD, Ludher BS, Johnston KP: Low viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles. Langmuir. 2010 Jan 19;26(2):1067-74. Apparent viscosities below this limit are reported for suspensions of milled lysozyme microparticles up to nearly 400 mg/mL in benzyl benzoate or benzyl benzoate mixtures with safflower oils through a syringe with a 25- to 27-gauge needle at room temperature. |
7(0,0,1,2) | Details |